| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $18.0M | -25.1% |
| Cost of Revenue | $14.9M | -26.6% |
| Gross Profit | $3.1M | -16.6% |
| R&D Expense | $200K | -2.9% |
| SG&A Expense | $3.7M | -2.5% |
| Operating Income | -$1.1M | -121.4% |
| Interest Expense | $450K | -20.3% |
| Pre-tax Income | -$1.5M | +81.0% |
| Net Income | -$1.5M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $146K | +121.8% |
| Accounts Receivable | $1.6M | -53.0% |
| Inventory | $8.3M | +5.7% |
| Current Assets | $10.5M | -16.0% |
| Total Assets | $15.3M | -11.6% |
| Current Liabilities | $7.5M | -27.9% |
| Long-term Debt | $4.9M | -29.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.4M | +163.8% |
| Capital Expenditures | $163K | +33.6% |
| Investing Cash Flow | -$163K | -104.8% |
| Financing Cash Flow | -$2.1M | -439.5% |
| Free Cash Flow | $2.2M | +157.5% |
| +82.3% |
| EPS (Basic) | -$0.22 | +89.1% |
| EPS (Diluted) | -$0.22 | +89.1% |
| Total Liabilities |
| $12.5M |
| -5.3% |
| Stockholders' Equity | $2.7M | -32.2% |